CTFA oral health care petition
This article was originally published in The Rose Sheet
Executive Summary
Comment extension for OTC antigingivitis/antiplaque drug products proposed monograph requested by the Cosmetic, Toiletry & Fragrance Association and the Consumer Healthcare Products Association in July 15 petition to FDA. Delaying due date for comments by 90 days to Nov. 25, instead of Aug. 25, would allow industry to prepare material addressing FDA's decision to classify several active ingredients as Category III, rather than Category I, the groups state. CTFA, CHPA also request 90-day delay of the reply comment period. Associations argue industry needs time to reply to agency's call for statistical protocol and efficacy data on certain combination products before tentative final monograph is published. Notice of proposed rulemaking was published May 29 (1"The Rose Sheet" June 2, 2003, p. 3)...
You may also be interested in...
Antiplaque Comments
New date for comments on advance notice of proposed rulemaking for OTC Antigingivitis/ Antiplaque Drug Products is Nov. 25, FDA announces. Reply comment period also has been extended to Feb. 23, 2004, agency says in Federal Register notice slated to appear Aug. 25. CHPA, CTFA jointly requested the extension in a July 15 petition (1"The Rose Sheet" July 28, 2003, In Brief). Groups wanted extra time to review data on ingredients the agency has proposed classifying as Category III (insufficient data) rather than Category I (safe and effective)...
Antigingivitis/Antiplaque Combination With Other Actives Excluded In ANPR
FDA's advance notice of proposed rulemaking on OTC antigingivitis/antiplaque products excludes the combination of antigingivitis/antiplaque ingredients with other oral health care ingredients. The 1notice was published in the May 29 Federal Register
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.